Retatrutide is drawing attention for an encouraging reason: in Eli Lilly’s clinical trials, this investigational medicine produced substantial weight loss and showed potential across several health conditions linked with obesity.
How it works
Retatrutide is designed to activate three hormone receptors—GIP, GLP-1 and glucagon—that play roles in appetite, blood sugar and metabolism. Researchers are studying whether this “triple agonist” approach can offer a valuable new option for people managing obesity and related conditions.
What Lilly’s trials found
In TRIUMPH-1, a Phase 3 trial in adults with obesity or overweight and a weight-related health condition, participants taking the highest studied dose lost an average of 25.0% of their body weight after 80 weeks, compared with 3.9% among those taking placebo. In a study extension involving participants with a BMI of at least 35, average weight loss reached 29.9% at 104 weeks for those assigned to the 12 mg dose.
The findings extend beyond people without diabetes. In TRIUMPH-2, adults with obesity or overweight and type 2 diabetes taking the highest studied dose lost an average of 20.8% of their body weight after 80 weeks. The trial also reported an average A1C reduction of up to 1.6 percentage points.
These Phase 3 results build on an earlier Phase 2 study published in The New England Journal of Medicine. At 48 weeks, participants taking 12 mg lost an average of 24.2% of their body weight, compared with 2.1% in the placebo group.
Why the results matter
The results offer a hopeful signal: for some participants, retatrutide was associated with substantial weight reduction, and researchers are investigating its potential for conditions that often accompany obesity. It is still important to remember that trial averages do not predict an individual’s results, and the studies enrolled specific groups of participants under clinical supervision.
What does Reta do for the non obese?
This past year, I’ve been taking Retatrutide, along with several handfuls of friends/clients. In my first 3 weeks, I lost 13lbs, my arthritis in my knees felt better and I was no longer bloated. I was digesting food properly, without the bloating, my appetite was suppressed just enough to allow my caloric deficit to feel non existent. Getting ripped up for this past summer felt more effortless than ever before. I was able to keep my muscle, burn my fat all while staying comfortable and avoiding the up and downs of my previous fat cutting experiences. Retatrutide is the most powerful metabolic signalling tool I’ve ever used, and I’ve been doing this a very long time! One thing I will note, you do not need anywhere near the 8-12mg’s the trials used to achieve the results, I never went higher then 3.5mg/week, losing 25lbs in total, while putting on 10lbs of muscle over 8 months!
Conclusion
Retatrutide’s trial results offer an encouraging glimpse of what future obesity treatments may achieve. While it remains investigational and more research is needed, the findings highlight the potential of new approaches to support meaningful weight loss and improve related health measures. For those who don’t want to wait and are ready to use an amazing product at a 10th of the future pharmaceutical cost, contact us at [email protected] and get started today!
Team Faer
Signal Retatrutide 12mg
Unlock powerful fat loss and metabolic support with Signal Retatrutide, a premium triple-agonist peptide designed to enhance weight reduction, improve energy expenditure, and control appetite. Favored for its advanced GLP-1/GIP/glucagon receptor activity, it helps achieve a leaner physique while supporting overall metabolic health.
Retatrutide is the most powerful and effective weight loss drug ever made, according to trial data!
